Robert Stockton Jones Jr.

Array ( [id] => 6762023 [patent_doc_number] => 20030125385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy' [patent_app_type] => new [patent_app_number] => 10/194021 [patent_app_country] => US [patent_app_date] => 2002-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 29039 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125385.pdf [firstpage_image] =>[orig_patent_app_number] => 10194021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7261663 [patent_doc_number] => 20040241224 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Methods and materials for the treatment of testosterone deficiency in men' [patent_app_type] => new [patent_app_number] => 10/483458 [patent_app_country] => US [patent_app_date] => 2004-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4787 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241224.pdf [firstpage_image] =>[orig_patent_app_number] => 10483458 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6813278 [patent_doc_number] => 20030072828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-17 [patent_title] => 'Natural therapeutic composition for the treatment of wounds and sores' [patent_app_type] => new [patent_app_number] => 10/188828 [patent_app_country] => US [patent_app_date] => 2002-07-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2974 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20030072828.pdf [firstpage_image] =>[orig_patent_app_number] => 10188828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6744653 [patent_doc_number] => 20030021836 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Magnesium di-potassium EDTA complex and method of administration' [patent_app_type] => new [patent_app_number] => 10/189330 [patent_app_country] => US [patent_app_date] => 2002-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1496 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20030021836.pdf [firstpage_image] =>[orig_patent_app_number] => 10189330 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 938462 [patent_doc_number] => 06972291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-12-06 [patent_title] => 'Method for reducing food intake' [patent_app_type] => utility [patent_app_number] => 10/187578 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4963 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/972/06972291.pdf [firstpage_image] =>[orig_patent_app_number] => 10187578 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6745635 [patent_doc_number] => 20030022818 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-30 [patent_title] => 'Formulations of tocopherols and methods of making and using them' [patent_app_type] => new [patent_app_number] => 10/188587 [patent_app_country] => US [patent_app_date] => 2002-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28211 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20030022818.pdf [firstpage_image] =>[orig_patent_app_number] => 10188587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6761946 [patent_doc_number] => 20030125308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Antipruritic agents for external use' [patent_app_type] => new [patent_app_number] => 10/169200 [patent_app_country] => US [patent_app_date] => 2002-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4445 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20030125308.pdf [firstpage_image] =>[orig_patent_app_number] => 10169200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6870695 [patent_doc_number] => 20030083385 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Use of benzenesulfonyl (thioureas or ure as) for treating of septic shock or gene ralized inflammatory syndrome' [patent_app_type] => new [patent_app_number] => 10/178648 [patent_app_country] => US [patent_app_date] => 2002-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20030083385.pdf [firstpage_image] =>[orig_patent_app_number] => 10178648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711598 [patent_doc_number] => 20030171347 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Sigma receptor antagonists having anti-cocaine properties and uses thereof' [patent_app_type] => new [patent_app_number] => 10/178859 [patent_app_country] => US [patent_app_date] => 2002-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 15383 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171347.pdf [firstpage_image] =>[orig_patent_app_number] => 10178859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6751043 [patent_doc_number] => 20030045564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Saururus chinensis extract for prevention and treatment of neurodegenerative disease' [patent_app_type] => new [patent_app_number] => 10/168395 [patent_app_country] => US [patent_app_date] => 2002-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7007 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20030045564.pdf [firstpage_image] =>[orig_patent_app_number] => 10168395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 401274 [patent_doc_number] => 07291639 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-11-06 [patent_title] => 'Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1)' [patent_app_type] => utility [patent_app_number] => 10/171056 [patent_app_country] => US [patent_app_date] => 2002-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3451 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/291/07291639.pdf [firstpage_image] =>[orig_patent_app_number] => 10171056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6818351 [patent_doc_number] => 20030069309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => '6-Methoxy-2-naphthylacetic acid prodrugs' [patent_app_type] => new [patent_app_number] => 10/170800 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2946 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0069/20030069309.pdf [firstpage_image] =>[orig_patent_app_number] => 10170800 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6736117 [patent_doc_number] => 20030013752 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-16 [patent_title] => 'Method for administration of cancer therapeutic' [patent_app_type] => new [patent_app_number] => 10/170080 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2030 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20030013752.pdf [firstpage_image] =>[orig_patent_app_number] => 10170080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825594 [patent_doc_number] => 20030236216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => '4\'-substituted nucleoside derivatives as inhibitors of HCV RNA replication' [patent_app_type] => new [patent_app_number] => 10/167106 [patent_app_country] => US [patent_app_date] => 2002-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10961 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20030236216.pdf [firstpage_image] =>[orig_patent_app_number] => 10167106 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 54202 [patent_doc_number] => 07767702 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-03 [patent_title] => 'Substituted oxazolidinones for combinational therapy' [patent_app_type] => utility [patent_app_number] => 10/481297 [patent_app_country] => US [patent_app_date] => 2002-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25672 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/767/07767702.pdf [firstpage_image] =>[orig_patent_app_number] => 10481297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688909 [patent_doc_number] => 20030032634 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance' [patent_app_type] => new [patent_app_number] => 10/159280 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 11671 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032634.pdf [firstpage_image] =>[orig_patent_app_number] => 10159280 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774737 [patent_doc_number] => 20030018075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Suppressors of anemia and appetite suppressors and methods for suppressing anemia and suppressing appetite' [patent_app_type] => new [patent_app_number] => 10/158059 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8175 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018075.pdf [firstpage_image] =>[orig_patent_app_number] => 10158059 [rel_patent_id] =>[rel_patent_doc_number] =>)